Effectiveness of complement inhibitors against refractory antibody-mediated rejection of lung transplantation: Two clinical cases
{{output}}
Antibody-mediated rejection (AMR) has been recognized as a significant cause of acute and chronic lung allograft dysfunction after lung transplantation. Some treatments, eculizumab, an anti-complement (C)5 component monoclonal antibody (Mab), seem to have a pr... ...
